New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial
60% Complete Response Rate after JELMYTO Induction 25% of Patients Received a Ureteral Stent ...
Source: marketscreener.com